D-0600-2021 Class II Terminated
FDA drug recall D-0600-2021 was initiated by Boehringer Ingelheim Pharmaceuticals, Inc. on May 4, 2021 and is designated Class II. Reason for recall: Subpotent Drug The recall status is terminated (terminated Oct 14, 2021). Affected quantity: 15,198 bottles (30 tablets per bottle).
Recall details
- Product Type
- Drugs
- Report Date
- Jun 9, 2021
- Initiation Date
- May 4, 2021
- Termination Date
- Oct 14, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 15,198 bottles (30 tablets per bottle)
Product description
Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877
Reason for recall
Subpotent Drug
Distribution pattern
AR, CO, CT, LA, NC, ND, NH, NJ, OH, PA and PR
Code information
Lot #860412; SEPT 2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0600-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026